COQ9
Ubiquinone biosynthesis protein COQ9, mitochondrial
Also known as: C16orf49, COQ9_HUMAN, DKFZP434K046
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75208
- Gene
- COQ9
- Ensembl
- ENSG00000088682
- Chromosome
- 16
- Canonical length
- 318 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Mitochondria,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This locus represents a mitochondrial ubiquinone biosynthesis gene. The encoded protein is likely necessary for biosynthesis of coenzyme Q10, as mutations at this locus have been associated with autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency.[provided by RefSeq, Sep 2010]
Canonical amino-acid sequenceUniProt
318 residues, UniProt reviewed canonical sequence.
>O75208|COQ9
1 MAAAAVSGAL GRAGWRLLQL RCLPVARCRQ ALVPRAFHAS AVGLRSSDEQ KQQPPNSFSQ
61 QHSETQGAEK PDPESSHSPP RYTDQGGEEE EDYESEEQLQ HRILTAALEF VPAHGWTAEA
121 IAEGAQSLGL SSAAASMFGK DGSELILHFV TQCNTRLTRV LEEEQKLVQL GQAEKRKTDQ
181 FLRDAVETRL RMLIPYIEHW PRALSILMLP HNIPSSLSLL TSMVDDMWHY AGDQSTDFNW
241 YTRRAMLAAI YNTTELVMMQ DSSPDFEDTW RFLENRVNDA MNMGHTAKQV KSTGEALVQG
301 LMGAAVTLKN LTGLNQRRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against COQ9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 239 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 239 nTPM
- tongue: 225 nTPM
- heart muscle: 139 nTPM
- parathyroid gland: 75 nTPM
- choroid plexus: 72 nTPM
- kidney: 68 nTPM
Single-cell type
- myonuclei: 104 nCPM
- syncytiotrophoblasts: 84 nCPM
- cytotrophoblasts: 77 nCPM
- enterocytes: 73 nCPM
- esophageal apical cells: 72 nCPM
- choroid plexus epithelial cells: 69 nCPM
Immune cell
- non-classical monocyte: 38 nTPM
- intermediate monocyte: 37 nTPM
- myeloid DC: 34 nTPM
- classical monocyte: 28 nTPM
- naive CD8 T-cell: 26 nTPM
- T-reg: 26 nTPM
Brain region
- choroid plexus: 61 nTPM
- cerebral cortex: 34 nTPM
- thalamus: 32 nTPM
- cerebellum: 29 nTPM
- basal ganglia: 27 nTPM
- hypothalamus: 26 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about COQ9.
Disease | AllUniProt
Conditions COQ9 is implicated in, by any mechanism.
- Coenzyme Q10 deficiency, primary, 5 (COQ10D5) MIM:614654
Disease | GeneticClinVar
25 pathogenic / likely-pathogenic of 364 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome
- Lung cancer
- Inborn genetic diseases
- Melanoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.01
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.22
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- enzyme activator activity
- lipid binding
- protein homodimerization activity
- isoprenoid binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ubiquinone biosynthesis protein COQ9
- COQ9, C-terminal domain
- Ubiquinone biosynthesis protein COQ9, HTH domain
- COQ9
- Ubiquinone biosynthesis protein COQ9, N-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of COQ9 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads COQ9 as an antibody target. Whether an autoantibody or antibody against COQ9 could matter depends on whether native COQ9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
COQ9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label COQ9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...